A price target is an analyst’s estimate of what a stock may be worth, based on forecasts and a valuation method. For a health insurer, that estimate can depend on projected earnings or cash flows, the multiple applied to those forecasts, and operating assumptions such as medical costs and business mix. It is a model result—not a promise that the share price will reach that level.
What a stock price target tells you
An analyst typically forecasts a company’s financial performance, chooses a way to value it, and converts the result into an estimated value per share. The target therefore reflects both the forecast and the analyst’s judgments about how the market should value the business.
A target is not the same as a guaranteed future price or an objective measure independent of assumptions. Two analysts can examine the same insurer and reach different targets because they use different earnings or cash-flow forecasts, valuation methods, multiples, peer groups, or views of risk.
How analysts calculate a target
Forecast earnings and apply a P/E multiple
One common approach is to estimate earnings per share (EPS) for a forecast period and multiply that estimate by a price-to-earnings (P/E) multiple. In simple terms, the calculation is forecast EPS × selected P/E multiple = implied share value.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
#1 Best Overall
The P/E ratio is the share price divided by annual earnings per share. The Centers for Medicare & Medicaid Services (CMS) describes it as a way to show what the market is willing to pay for a company’s stock as a multiple of its earnings. In its managed-care report, CMS used P/E for relative comparisons; its comparison covered 1995–2002, so it is historical context, not a current benchmark for valuing an insurer. CMS’s managed-care analysis
The selected multiple is an assumption, not a fixed property of the company. It may reflect expected growth, perceived risk, business quality, and how comparable companies are valued. If either the EPS forecast or the multiple changes, the implied value changes too.
Rank #2
Estimate and discount future cash flows
A discounted cash flow (DCF) analysis estimates future cash flows and discounts them to today’s value. The discount rate reflects the time value of money and risk; analysts also make assumptions about cash flows beyond the explicit forecast period, often represented by a terminal value. Debt treatment matters when translating enterprise value into equity value per share.
A 2018 transaction filing describing Cigna’s DCF analysis illustrates how forecast cash flows, discount rates, terminal-value assumptions, and net debt can affect the equity-value calculation. Those transaction-specific figures are examples of modeling inputs used at that time, not current assumptions for a health-insurer stock target. Cigna transaction filing
Use other methods or combine them
Analysts may also use earnings, cash-flow, or EBITDA multiples; peer comparisons; sum-of-the-parts; net asset value; dividend methods; or return on equity. A May 21, 2025 Jefferies report about CMS Info Systems—not a health insurer—describes this range of approaches. It illustrates that methodology varies by company and report; it does not establish a preferred method or current valuation input for health insurers. Jefferies report on CMS Info Systems
Why medical loss ratio matters for insurer forecasts
The medical loss ratio (MLR) measures the share of premium revenue spent on clinical services and quality improvement. The Affordable Care Act requires health insurance issuers to report this proportion. Federal rules generally require insurers to spend at least 80% or 85% of premium dollars on medical care, depending on the applicable market; issuers that fall short of the applicable standard must provide rebates. CMS Medical Loss Ratio overview
MLR can help an analyst assess the relationship between premium revenue and medical spending, but its impact on earnings is company-specific. When reading a target, look for whether the analyst explains recent claims experience, the insurer’s business mix, and the MLR assumptions behind the earnings forecast. Do not assume a given change in MLR produces the same earnings effect at every insurer.
Scope matters: the National Association of Insurance Commissioners (NAIC) says MLR is calculated from annual aggregate financial allocations by market and state. A figure for one market or state should not automatically be treated as representative of a diversified insurer’s entire business. NAIC’s accessed page reports that 2023 rebates, paid in 2024, totaled $947 million for about 6.1 million families—an average of $156 per family. These are the latest figures stated on that page, not a forecast or a measure of any one company’s future results. NAIC medical loss ratio data
Recommended Free Tools
S&P Global also identifies MLR as a key health-insurer KPI because it indicates how much of premium dollars goes to medical care and quality improvement rather than other costs. S&P Global’s health-insurer KPI overview
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.How to compare two analyst targets
A higher target does not necessarily mean an analyst expects the stock to outperform by more. It can result from higher expected earnings, a higher valuation multiple, different cash-flow assumptions, or a different view of risk. Compare the underlying inputs rather than the headline numbers:
- Forecast: Which period does each analyst cover, and what earnings or cash flows does each project?
- Valuation method: Is the target based on P/E, DCF, another method, or a combination?
- Multiple and comparables: If a multiple is used, what value and peer group were selected, and how are growth and risk reflected?
- DCF assumptions: Compare projected cash flows, discount rate, terminal value, and how debt is treated.
- Insurer operating assumptions: Does the report explain its MLR outlook, claims expectations, and treatment of the company’s different markets or businesses?
- Time horizon and date: Check the report’s stated horizon and publication date. There is no single universal time horizon established across analysts, and targets can become stale as forecasts or market conditions change.
What a price target cannot tell you by itself
A target alone does not show how reliable the forecast is, which assumptions drive the result, or how much uncertainty surrounds it. For a health insurer, the headline number is especially incomplete if the report does not explain its operating assumptions and how those assumptions flow into earnings or cash generation. Treat the target as a structured estimate to examine—not as a standalone reason to buy or sell.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
